GFM
TYRA icon

GF Fund Management’s Tyra Biosciences TYRA Stock Holding History

GF Fund Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.9K Buy
1,198
+150
+14% +$4.86K ﹤0.01% 409
2025
Q4 		$27.6K Sell
1,048
-99
-9% -$1.82K ﹤0.01% 474
2025
Q3 		$16K Sell
1,147
-149
-11% -$1.7K ﹤0.01% 517
2025
Q2 		$12.4K Hold
1,296
– – ﹤0.01% 543
2025
Q1 		$12.1K Buy
1,296
+233
+22% +$3.02K ﹤0.01% 539
2024
Q4 		$14.8K Buy
+1,063
New +$19.3K ﹤0.01% 499

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

GF Fund Management's TYRA Position: Q1 2026 in Review

GF Fund Management increased its Tyra Biosciences (TYRA) stake by 14% in Q1 2026, buying an estimated $4.86K and bringing the position to 1,198 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #409.

GF Fund Management first reported a position in TYRA in Q4 2024 and has held it in 6 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • GF Fund Management held 1,198 shares of Tyra Biosciences worth $45.9K as of Q1 2026.
  • GF Fund Management bought 150 Tyra Biosciences shares in Q1 2026, an estimated $4.86K.
  • Tyra Biosciences made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #409 holding.
  • GF Fund Management first reported a position in Tyra Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.